Correa-Valdez M, Castillo-Barón S, Olivas-Flores EM

Idioma: Español
Referencias bibliográficas: 20
Paginas: 121-127
Archivo PDF: 823.30 Kb.

FRAGMENTO

El trasplante renal se consolida como el tratamiento de elección para la enfermedad renal crónica terminal, superando a la diálisis en términos de supervivencia y calidad de vida. No obstante, la función retardada del injerto (Delayed Graft Function [DGF]) persiste como un desafío clínico significativo que compromete la viabilidad del órgano y aumenta los costos hospitalarios. En este escenario, el anestesiólogo emerge como una figura central, cuya intervención en el período perioperatorio inmediato es determinante para mitigar la lesión por isquemiareperfusión y asegurar una transición exitosa hacia la funcionalidad mediante un manejo hemodinámico meticuloso y proactivo.
La protección del injerto depende estrictamente de alcanzar metas tensionales precisas y un equilibrio metabólico óptimo. Mantener una presión arterial media entre 80 y 110 mmHg resulta vital para garantizar la perfusión de la microvasculatura del órgano denervado, evitando la estasis y complicaciones como la trombosis venosa.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Scott MJ, APSF Hemodynamic Instability Writing Group. Perioperativepatients with hemodynamic instability: consensus recommendations ofthe anesthesia patient safety foundation. Anesth Analg. 2024;138:713-724. Erratum in: Anesth Analg. 2025;140:e18. doi: 10.1213/ANE.0000000000007300.

2. Goyal VK, Shekhrajka P, Mittal S. Perioperative considerations in kidneytransplantation: An anaesthesiologist’s perspective. World J Transplant.2025;15:107662. doi: 10.5500/wjt.v15.i4.107662.

3. Lee J, Kim MS. Considerations regarding anesthesia for renaltransplantation. Anesth Pain Med (Seoul). 2024;19:6-16. doi: 10.17085/apm.23153.

4. Collins MG, Fahim MA, Pascoe EM, Hawley CM, Johnson DW,Varghese J, et al. Balanced crystalloid solution versus saline in deceaseddonor kidney transplantation (BEST-Fluids): a pragmatic, double-blind,randomised controlled trial. Lancet. 2023;402:105-117. doi: 10.1016/S0140-6736(23)00642-6.

5. Morrison SA, Thanamayooran A, Tennankore K, Vinson AJ. Associationbetween perioperative hypotension and graft function in kidneytransplantation. Kidney Int Rep. 2025;10:1819-1828. doi: 10.1016/j.ekir.2025.03.055.

6. Bajpai D, Muthukumar T. Post-transplant hypotension in kidneyrecipients-vasopressin to the rescue? Kidney Int Rep. 2022;7:1161-1164.doi: 10.1016/j.ekir.2022.05.001.

7. Bajpai D, Puttarajappa CM. Chronic hypotension and transplantoutcomes-the known unknowns. Kidney Int Rep. 2024;9:1571-1573.doi: 10.1016/j.ekir.2024.04.065.

8. Wan SS, Wyburn K, Chadban SJ, Collins MG. Balanced electrolytesolutions versus 0.9% saline for kidney transplantation: An updatedsystematic review and meta-analysis. Transplantation. 2024;108:491-501. doi: 10.1097/TP.0000000000004739.

9. Klonarakis MP, Dhillon M, Sevinc E, Elliott MJ, James MT, LamNN, et al. The effect of goal-directed fluid therapy on delayed graftfunction in kidney transplant recipients: A systematic review and metaanalysis.Transplant Rev (Orlando). 2024;38:100834. doi: 10.1016/j.trre.2024.100834.

10. Cavaleri M, Veroux M, Palermo F, Vasile F, Mineri M, Palumbo J, etal. Perioperative goal-directed therapy during kidney transplantation:An impact evaluation on the major postoperative complications. J ClinMed. 2019;8:80. doi: 10.3390/jcm8010080.

11. Abou Taka M, Dugbartey GJ, Sener A. the optimization of renal graftpreservation temperature to mitigate cold ischemia-reperfusion injuryin kidney transplantation. Int J Mol Sci. 2022;24:567. doi: 10.3390/ijms24010567.

12. Dolla C, Mella A, Vigilante G, Fop F, Allesina A, Presta R, et al.Recipient pre-existing chronic hypotension is associated with delayedgraft function and inferior graft survival in kidney transplantation fromelderly donors. PLoS One. 2021;16:e0249552. doi: 10.1371/journal.pone.0249552.

13. Avila-Poletti D, De Azevedo L, Iommi C, Heldal K, Musso CG.Hyperchloremic metabolic acidosis in the kidney transplant patient.Postgrad Med. 2019;131:171-175. doi: 10.1080/00325481.2019.1592360.

14. Kim H, Jung H. Considerations regarding anesthesia for renaltransplantation. Anesth Pain Med (Seoul). 2024;19:5-11. doi: 10.17085/apm.23153.

15. Cristiana L, Lorenzo G, Giovanni V, Chiara G, Matteo R, Gaetano M, et al.Impact of intraoperative goal-directed therapy on perioperative outcomesin kidney transplantation: a multicenter randomized controlled trial. InternEmerg Med. 2026;21:1373-1383. doi: 10.1007/s11739-025-04021-2.

16. Fabes J, Al Midani A, Sarna AS, Hadi DH, Naji SA, Banga NR, etal. Goal-directed haemodynamic therapy improves patient outcomesin kidney transplantation. Prog Transplant. 2023;33:150-155. doi:10.1177/15269248231164165.

17. Sen IM, Subramanyam R, Singh S. The effect of pulse pressurevariation compared with central venous pressure on intraoperative fluidmanagement during kidney transplant surgery: a randomized controlledtrial. Can J Anaesth. 2022;69:62-71. doi: 10.1007/s12630-021-02130-y.

18. Pongpruksa C, Khampitak N, Chang D, Bunnapradist S, Gritsch H, XiaVW. Intraoperative mean arterial pressure and postoperative delayedgraft function in kidney transplantation: evaluating three commonly usedthresholds. Clin Transplant. 2024;38:e15458. doi: 10.1111/ctr.15458.

19. Chang Y, Qin Y, Zou Y, Zeng H, Li C, Qin M, et al. Plasma-lyte solutionversus saline in kidney transplantation: A systematic review and metaanalysisof randomized controlled trials. PLoS One. 2025;20:e0320082.doi: 10.1371/journal.pone.0320082.

20. Smyrli M, Sarafidis PA, Loutradis C, Korogiannou M, Boletis IN,Marinaki S. Prevalence and factors associated with hyperkalaemia instable kidney transplant recipients. Clin Kidney J. 2021;15:43-50. doi:10.1093/ckj/sfab129.